Arpitha Chikkanna is a PhD candidate currently working on designing novel Antisense Oligonucleotides (ASOs) as a therapeutic option for chronic kidney conditions. In patients with these conditions, kidney metabolism is not as efficient as in normal individual. To elaborate on this, Arpitha is designing and fine-tuning the ASOs to target the hallmark gene of the disease. She hopes to achieve a lead candidate that can improve kidney metabolism thereby benefits the patients therapeutically.

View Publications    Email